Is predicting metastatic phaeochromocytoma and paraganglioma still effective without methoxytyramine?

Lancet Digit Health. 2024 Mar;6(3):e154. doi: 10.1016/S2589-7500(24)00019-0.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adrenal Gland Neoplasms* / pathology
  • Dopamine / analogs & derivatives*
  • Humans
  • Paraganglioma* / pathology
  • Pheochromocytoma* / pathology
  • Pheochromocytoma* / secondary

Substances

  • 3-methoxytyramine
  • Dopamine